Incidence and prognostic factors of primary thyroid lymphoma and construction of prognostic models for post-chemotherapy and postoperative patients: a population-based study
Open Access
- 13 April 2021
- journal article
- research article
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 21 (1) , 1-15
Abstract
Background: Primary thyroid lymphoma (PTL) is a rare thyroid malignancy, there are few large sample studies on PTL and no standardized treatment regimen has been established due to the rarity. The aims of this study were to explore the incidence and prognostic factors of PTL and construct visual prognostic prediction models for post-chemotherapy and postoperative patients. Methods: The incidence of PTL in 1975–2017 was extracted from the US Surveillance, Epidemiology, and End Results (SEER) database, then assessed using joinpoint regression software. A total of 1616 eligible PTL patients diagnosed in 1998–2016 were brought into prognostic analysis. Multivariate Cox regression analyses were carried out to reveal independent prognostic elements for overall survival (OS) and cancer-specific survival (CSS). Results: PTL incidence showed a relatively steady increase in 1975–1994, which annual percent change (APC) was 4.0%, and steady decreasing in 1994–2017(APC − 2.4%). Age, marital status, lymphoma Ann Arbor stage, histological subtypes, surgery, chemotherapy, and radiation were significantly correlated to OS and CSS. Nomograms were constructed to predict OS and CSS in post-chemotherapy and postoperative PTL patients separately, and were verified to have good reliability. Conclusions: The incidence of PTL increased and subsequently decreased. We revealed the prognostic implications and constructed reliable nomograms for post-chemotherapy and postoperative PTL patients.Keywords
All Related Versions
This publication has 25 references indexed in Scilit:
- Improving survival and preventing recurrence of diffuse large B-cell lymphoma in younger patients: current strategies and future directionsOncoTargets and Therapy, 2013
- Primary thyroid lymphoma: The 40 year experience of a UK lymphoma treatment centreInternational Journal of Oncology, 2012
- Cytodiagnosis of primary thyroid lymphoma with histologic correlation: A case reportDiagnostic Cytopathology, 2011
- Clinicopathological features of 171 cases of primary thyroid lymphoma: a long‐term study involving 24 553 patients with Hashimoto’s diseaseBritish Journal of Haematology, 2011
- Prognosis of primary thyroid lymphoma: Demographic, clinical, and pathologic predictors of survival in 1,408 casesSurgery, 2009
- Thyroid diffuse large B cell lymphoma (DLBCL) following thyroid medullary cancer: long-term complete remission with R-CHOP therapyAnnals of Hematology, 2008
- Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study GroupBlood, 2005
- Primary thyroid lymphomasCurrent Treatment Options in Oncology, 2004
- Malignant Lymphoma of the Thyroid GlandAmerican Journal of Surgical Pathology, 2000
- Cancer Risks in Patients with Chronic Lymphocytic ThyroiditisNew England Journal of Medicine, 1985